•Protective effect of a newly probiotic Lactobacillus reuteri LY2-2 on DSS-induced colitis
•Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
•The therapeutic efficacy of adipose mesenchymal stem cell-derived microvesicles versus infliximab in a dextran sodium sulfate induced ulcerative colitis rat model
•Vascular endothelial growth factor in inflammatory bowel disease: A systematic review and meta-analysis
•A Novel Colon-Targeting Ratiometric Probe with Large Emission Shift for Imaging Peroxynitrite in Ulcerative Colitis